Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission

Clinical trial NCT02126553 · COMPLETED

Trial details

NCT number: NCT02126553
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alkylating Agent-Related Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia

Start date: 2014-11-13
Primary completion: 2021-11-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.